Related Experiment Videos
Recent advances in antihypertensive therapy
1Department of Medicinal Chemistry, Prassis Istituto di Ricerche Sigma-Tau, Settimo Milanese, Italy.
Insights
Current hypertension treatments remain diverse due to the disease's complexity. This review explores established and novel therapeutic strategies for managing high blood pressure, including emerging drug targets.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Hypertension is a complex, multifactorial condition often linked with other cardiovascular issues.
- Existing antihypertensive medications do not offer a universal cure, necessitating ongoing therapeutic research.
Purpose of the Study:
- To review established and innovative therapeutic approaches for hypertension.
- To highlight current developments in antihypertensive drug discovery and mechanisms.
Main Methods:
- Review of existing literature on antihypertensive drug classes.
- Analysis of emerging research on novel therapeutic targets and mechanisms.
Main Results:
- Established drug classes (adrenergic agents, diuretics, calcium antagonists) are still in use.
- New research focuses on the renin-angiotensin system, endothelium, and ionic channels.
- Experimental compounds targeting phosphodiesterase, neuropeptide Y, and ouabain-like factors show promise.
Conclusions:
- The treatment landscape for hypertension is dynamic, integrating traditional and novel strategies.
- Advances in understanding blood pressure homeostasis are driving innovative therapeutic development.
- A multifaceted approach is essential for effective hypertension management.
Abstract:
There are multiple different approaches that have been adopted in the past to cure hypertension. Hypertension is a multifactorial disease frequently associated with other cardiovascular problems. None of the antihypertensive drugs available can cure all cases of hypertension. This situation causes a unique scenario in this area of therapeutic research: less recent approaches, which make use of drugs acting on the adrenergic system, diuretics, calcium antagonists, nitro-vasodilators and so on, have not yet been abandoned, while new compounds are still being developed today. Newly acquired and more detailed knowledge of the renin-angiotensin system, of the role of the endothelium and ionic channels in the homeostasis of blood pressure has opened up new lines of study. There are also a number of experimental compounds targeted for other action mechanisms (phosphodiesterase inhibitors, neuropeptide Y antagonists, ouabain-like factor antagonists), that could also represent innovative approaches to hypertension therapy. Some hints regarding the current developments in the well established and innovative categories of antihypertensives will be given in this review.